Preterm infants with bronchopulmonary dysplasia
Conditions
Interventions
None listed
Sponsors
Life Science Research Center, Nagano Children's Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: - Studies involving preterm infants (<37 weeks GA) with bronchopulmonary dysplasia (BPD) - Home oxygen therapy (HOT) initiated at NICU discharge - Descriptions of home monitoring devices (e.g., pulse oximeters) - Inclusion of clinical outcomes such as mortality, development, growth, duration of HOT, and family QOL - Study types: RCTs, prospective/retrospective cohort studies, and case-control studies - Published in Japanese or English - Conducted in developed countries (HDI >= 0.8) - Guidelines may also be included
Exclusion criteria
Exclusion criteria: - Case reports, books, theses, review articles, non-peer-reviewed publications - Basic science or animal studies - Studies focusing on chronic lung disease other than BPD (e.g., congenital malformations, chromosomal abnormalities) - Studies with no reference to monitoring practices
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To identify the actual practices and management methods of home monitoring devices (e.g., pulse oximeters) in preterm infants with neonatal chronic lung disease, and to examine their effectiveness in relation to mortality, physical and neurodevelopmental outcomes, physical growth, duration of home oxygen therapy, and family quality of life. | — |
Secondary
| Measure | Time frame |
|---|---|
| To identify reasons for not conducting home monitoring, to explore the detailed impact of home monitoring on family quality of life (including caregiver burden and psychological effects), and to summarize variations in monitoring practices or guidelines across countries and institutions, as well as the availability of training and support systems related to home monitoring devices. | — |
Countries
Japan
Contacts
Public ContactRyo Ogawa
Nagano Children's Hospital Division of Neonatology
Outcome results
None listed